A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML.

ABSTRACT:

SUBMITTER: Gopal S 

PROVIDER: S-EPMC6058230 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature